Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Induction of Allergen Specific Bronchial Immunotolerance After Specific Immunotherapy (ITASIT)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stefan Zielen, Johann Wolfgang Goethe University Hospitals
ClinicalTrials.gov Identifier:
NCT01479205
First received: November 22, 2011
Last updated: November 23, 2011
Last verified: November 2011